Immediate Impact
22 standout
Citing Papers
Current and future immunotherapeutic approaches in pancreatic cancer treatment
2024 Standout
BRAF — a tumour-agnostic drug target with lineage-specific dependencies
2024 Standout
Works of Ioannis Thomas being referenced
786 Intratumorally administered CV8102 in patients with advanced solid tumors: preliminary results from ongoing expansion part in study 008
2022
An open-label, single-arm, phase II trial of buparlisib in patients with melanoma brain metastases not eligible for surgery or radiosurgery—the BUMPER study
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ioannis Thomas | 53 | 43 | 42 | 12 | 152 | |
| James Reid | 78 | 73 | 25 | 11 | 185 | |
| Giorgia Saporiti | 23 | 48 | 39 | 18 | 164 | |
| Alfonso Navarro‐Zapata | 63 | 45 | 27 | 17 | 139 | |
| Bettina Bannert | 32 | 41 | 17 | 14 | 165 | |
| Cyrielle Robe | 51 | 33 | 62 | 11 | 170 | |
| Khoan Vu | 54 | 33 | 42 | 16 | 160 | |
| George J. Anday | 31 | 40 | 42 | 8 | 211 | |
| S. Thiebault | 30 | 32 | 44 | 10 | 117 | |
| Qianqian Hou | 47 | 24 | 74 | 16 | 202 | |
| Katherine P. Hoversten | 80 | 27 | 22 | 9 | 228 |
All Works
Login with ORCID to disown or claim papers
Loading papers...